Suzuki, Yasuhito
Shibata, Yoko
Minemura, Hiroyuki
Nikaido, Takefumi
Tanino, Yoshinori
Fukuhara, Atsuro
Kanno, Ryuzo
Saito, Hiroyuki
Suzuki, Shuzo
Inokoshi, Yayoi
Sando, Eiichiro
Sakuma, Hirofumi
Kobayashi, Tatsuho
Kume, Hiroaki
Kamimoto, Masahiro
Aoki, Hideko
Takama, Akira
Iizuka, Taku
Kamiyama, Takamichi
Nakayama, Masaru
Saito, Kiyoshi
Tanigawa, Koichi
Sato, Masahiko
Waragai, Yuichi
Kambe, Toshiyuki
Kanzaki, Norio
Azuma, Teruhisa
Okamoto, Hiromasa
Sakamoto, Keiji
Nakamura, Yuichi
Ohtani, Hiroshi
Waragai, Mitsuru
Maeda, Shinsaku
Ishida, Tokiya
Sugino, Keishi
Abe, Wataru
Tsukada, Yasuhiko
Lee, Tomoyoshi
Yamada, Ryuki
Sato, Riko
Onuma, Takumi
Tomita, Hikaru
Saito, Mikako
Watanabe, Natsumi
Rikimaru, Mami
Kawamata, Takaya
Morimoto, Julia
Togawa, Ryuichi
Sato, Yuki
Saito, Junpei
Kanazawa, Kenya
Hamaguchi, Sugihiro
Iseki, Ken
Funding for this research was provided by:
Japanese Society for the Promotion of Science (KAKENHI grant number 19K08658, and 22K10560)
Article History
Received: 30 September 2022
Accepted: 11 November 2022
First Online: 5 December 2022
Declarations
:
: Y Shibata and H Minemura received lecture fees and research grants from Chugai Pharmaceutical Co., Ltd. Y Shibata and J Saito received lecture fees from GlaxoSmithKline K.K. The other authors report no conflicts of interest related to this study.
: This study was performed in line with the principles of the Declaration of Helsinki. The protocol was approved by the local ethical committee.
: The authors have seen the final version of the manuscript and approved submission for publication.